Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.080
+0.010 (0.93%)
May 2, 2025, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $65.42 million as of May 2, 2025. Its market cap has decreased by -68.62% in one year.
Market Cap
65.42M
Enterprise Value
-136.40M
1-Year Change
-68.62%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $65.42M, a decrease of -89.42%. That is a compound annual growth rate of -44.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 65.42M | -36.69% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.09B |
| Johnson & Johnson | 371.64B |
| UnitedHealth Group | 364.71B |
| AbbVie | 342.01B |
| Novo Nordisk | 298.09B |
| Abbott Laboratories | 227.71B |
| Novartis AG | 223.05B |
| AstraZeneca | 218.59B |